glp 1 shortage GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors Trend Snapshot: The Ozempic Weight

You can learn about our specific treatment approach, current pricing, and session plans on our glutathione treatment service page

2,3 The REDEFINE 1 trial found that when evaluating the treatment effect regardless of whether patients stayed on treatment, those treated with CagriSema achieved weight loss of 20.4% (from an average baseline body weight of 236 lb.) at 68 weeks versus 3.0% (from an average baseline body weight of 235 lb.) for the placebo group which was statistically significant

Murray et al., 2014)

doi: 10.2337/dc18-0680, 73

Avoid injecting into bruised or tender areas

For a visual titration schedule with exact syringe units at every dose level, see the tirzepatide dosage chart in units